Bimekizumab 3-year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s305, 2024. DOI: 10.25251/skin.8.supp.305. Disponível em: https://skin.dermsquared.com/skin/article/view/2451. Acesso em: 30 apr. 2026.